Biocon Biologics Yesafili gets Health Canada nod for eye diseases Ruchika Sharma27 Jun 2025 11:36 AM ISTYESAFILI is the first biosimilar to EYLEA to be approved by Health Canada.
Aging Women with PANDO Face Higher Risk of Acute Dacryocystitis, suggests study Dr Riya Dave25 Jun 2025 8:45 PM ISTResearchers have discovered that age, especially in older women with primary acquired nasolacrimal duct obstruction (PANDO), strongly predicts the...
Real-World Data Shows Insulin Pumps May Cut Deaths, But Raise Retinopathy Risk in Type 1 Diabetes Medha Baranwal23 Jun 2025 9:00 AM ISTUK: A large-scale real-world analysis has revealed that insulin pump therapy offers significant survival benefits and lowers the risk of diabetic...
Phentolamine Eye Drops Improve Night Driving Post-Refractive Surgery in Phase 3 trial Dr. Kamal Kant Kohli20 Jun 2025 9:00 PM ISTResearchers have found in a phase 3 trial that phentolamine ophthalmic solution 0.75% led to significant improvements in mesopic low contrast distance...
Smart contact lens keeps an eye on your eyes-even when they're closed: Study Dr. Kamal Kant Kohli19 Jun 2025 9:00 PM ISTA new kind of smart contact lens is poised to revolutionize how we monitor eye health. Designed to work even when the eyes are closed, this...
Individuals with cataract at increased risk of developing herpes zoster: Study Jacinthlyn Sylvia17 Jun 2025 10:00 PM ISTA new study published in the journal of Frontiers in Medicine showed that the individuals with cataracts were more likely to get herpes zoster when...
Obstructive Sleep Apnea Doubles Risk of Severe Glaucoma Progression, Study Finds Medha Baranwal15 Jun 2025 9:00 PM ISTUSA: Patients diagnosed with obstructive sleep apnea (OSA) may be at a significantly higher risk of rapid glaucoma progression, according to a new...
FDA Approves Prednisolone Acetate Ophthalmic Suspension for Ocular Inflammation Dr. Kamal Kant Kohli13 Jun 2025 9:30 PM ISTThe FDA has approved preodnisolone acetate ophthalmic suspension, USP 1%, for treating steroid-responsive ocular inflammation. Amneal Pharmaceuticals...
Higher long-term variability of serum uric acid associated with diabetic retinopathy risk: Study Jacinthlyn Sylvia12 Jun 2025 9:30 PM ISTA new study published in the journal of Diabetes Research and Clinical Practice found that patients with type 1 and type 2 diabetes mellitus had a...
Semaglutide Use Tied to Slightly Increased nAMD Risk in Older Diabetic Patients: JAMA Medha Baranwal10 Jun 2025 8:45 PM ISTCanada: A recent observational cohort study from Canada revealed that older diabetic patients taking GLP-1 receptor agonists-primarily semaglutide-had...
Vitamin A Deficiency & the Risk of Diabetic Retinopathy, Unravelling the Link! Dr. Shravani Dali10 Jun 2025 8:45 AM ISTVitamin A deficiency has been observed to be associated with diabetic retinopathy. However, only a limited number of studies have explored this link...
Diabetes and Weight-Loss Drug Semaglutide Linked to Rare Eye Condition: European Medical Agency Dr. Bhumika Maikhuri10 Jun 2025 8:30 AM ISTThe European Medicines Agency's (EMA) Pharmacovigilance Risk Assessment Committee (PRAC) has concluded its review of semaglutide-containing medicines,...
